"Given the positive market response to its products and the momentum in the business, the Company has decided to accelerate investment in market access and sales management to maximise opportunities it sees for its products. Further, as noted above, the delayed opening of the new Royal Adelaide Hospital is anticipated to have an adverse impact. Accordingly, and taking into account performance in the first half, the Company expects the outlook for EBITDA loss excluding “exceptionals” to be at the top end of its range of $6-10M for the full year."
Ann: Half Yearly Report and Accounts, page-3
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |